October 17, 2013 / 5:47 AM / 4 years ago

Galapagos sees cystic fibrosis clinical trials in 2014

BRUSSELS, Oct 17 (Reuters) - Belgian biotech company Galapagos said on Thursday that it was set to start clinical trials on a possible treatment for cystic fibrosis at the end of 2014.

The company said in a statement that it had developed a series of potentiators following laboratory tests and would be presenting its results at the North America Cystic Fibrosis Conference in Utah on Oct 17-19.

Galapagos said it would nominate a pre-clinical candidate by the end of this year, with first clinical trials set to start at the end of 2014.

Galapagos signed a cooperation deal last month worth up to $405 million with U.S. company AbbVie to develop a new treatment for cystic fibrosis.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below